Safety and Efficacy of Abatacept Versus Placebo in Participants With Psoriatic Arthritis

Clinical trial NCT00534313 · TERMINATED

Trial details

NCT number: NCT00534313
Sponsor: Bristol-Myers Squibb
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Psoriatic Arthritis

Start date: 2007-11-01
Primary completion: 2008-12-01
Enrollment: 191

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.